ArticleFrontiers in oncology2022

Soluble PD-L1 Expression After Intravenous Treatment of Cancer Patients With Selenite in Phase I Clinical Trial.

Ali Razaghi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.